Kardigan, Inc. (KARD)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch KARD
See up to 3 months of KARD. The 7-day demo opens the 1M and 3M ranges and puts KARD on your watchlist.
Start 7-day demoLatest KARD insider trades
About Kardigan, Inc. (KARD)
Kardigan, Inc. is an SEC registrant, filing under CIK 0002123613, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site. Its offering priced on 18 June 2026 and it trades on NASDAQ.
KARD Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 48,368 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
KARD insider transactions (Form 4)
3917 Form 4 filings on record, the earliest from Jun 22, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Kristin Marie K. Reinke - Director | Grant or award | Stock Options (right to buy) | 48,368 | $0.00 | - | |
| PERCEPTIVE ADVISORS LLC | Grant or award | Common Stock | 20,706 | $0.00 | - | |
| HRTG GPE, LLC | Open-market purchase | Common Stock | 3,125,000 | $16.00 | $50.00M | |
| Paul L. Berns - Director | Open-market purchase | Common Stock | 1,250,000 | $16.00 | $20.00M | |
| ARCH Venture Partners XIII, LLC - Director | Open-market purchase | Common Stock | 1,250,000 | $16.00 | $20.00M | |
| HRTG GPE, LLC | Other | Common Stock | 3,242,993 | - footnote F1 | - | |
| HRTG GPE, LLC | Other | Common Stock | 2,348,373 | - footnote F1 | - | |
| HRTG GPE, LLC | Other | Series A Redeemable Convertible Preferred Stock | 1,287,146 | - footnote F1 | - | |
| HRTG GPE, LLC | Other | Series A Redeemable Convertible Preferred Stock | 3,861,440 | - footnote F1 | - | |
| HRTG GPE, LLC | Other | Series B Redeemable Convertible Preferred Stock | 2,036,033 | - footnote F1 | - | |
| HRTG GPE, LLC | Other | Series B-1 Redeemable Convertible Preferred Stock | 1,474,368 | - footnote F1 | - | |
| HRTG GPE, LLC | Other | Common Stock | 2,050,166 | - footnote F1 | - | |
| HRTG GPE, LLC | Other | Common Stock | 6,150,502 | - footnote F1 | - | |
| ||||||
| ARCH Venture Partners XIII, LLC | Other | Series B-1 Preferred Stock | 2,306,401 | - footnote F1 | - | |
| ARCH Venture Partners XIII, LLC | Other | Common Stock | 13,792,035 | - footnote F1 | - | |
| ARCH Venture Partners XIII, LLC | Other | Series A Preferred Stock | 5,148,587 | - footnote F1 | - | |
| ARCH Venture Partners XIII, LLC | Other | Series B Preferred Stock | 1,204,000 | - footnote F1 | - | |
| ||||||
 Andy Pasternak - Officer | Grant or award | Common Stock | 79,640 | $0.00 | - | |
| David P. Meeker | Grant or award | Common Stock | 20,706 | $0.00 | - | |
| Paul L. Berns | Other | Series B Preferred Stock | 1,204,000 | - footnote F1 | - | |
| Paul L. Berns | Other | Series B-1 Preferred Stock | 2,306,401 | - footnote F1 | - | |
| Paul L. Berns | Other | Common Stock | 13,792,035 | - footnote F1 | - | |
| Paul L. Berns | Grant or award | Common Stock | 20,706 | $0.00 | - | |
| Paul L. Berns | Other | Series A Preferred Stock | 5,148,587 | - footnote F1 | - | |
| ||||||
| John B. Moriarty - Officer | Grant or award | Common Stock | 47,784 | $0.00 | - | |
 Brianne Jahn - Officer | Grant or award | Common Stock | 79,640 | $0.00 | - | |
| Kimberly J. Popovits | Grant or award | Common Stock | 20,706 | $0.00 | - | |
 Timothy P. Walbert | Grant or award | Common Stock | 20,706 | $0.00 | - | |
| Timothy P. Walbert | Grant or award | Stock Option (Right to Buy) | 57,573 | $0.00 | - | |
| Anastasios Gianakakos - Officer | Other | Series A Preferred Stock | 18,020 | - footnote F1 | - | |
| Anastasios Gianakakos - Officer | Other | Series A Preferred Stock | 25,742 | - footnote F1 | - | |
| Anastasios Gianakakos - Officer | Other | Series B Preferred Stock | 313,092 | - footnote F1 | - | |
| Anastasios Gianakakos - Officer | Other | Common Stock | 28,702 | - footnote F1 | - | |
| Anastasios Gianakakos - Officer | Other | Common Stock | 41,001 | - footnote F1 | - | |
| Anastasios Gianakakos - Officer | Other | Common Stock | 498,692 | - footnote F1 | - | |
| ||||||
| Douglas E. Giordano | Grant or award | Common Stock | 20,706 | $0.00 | - | |
 Jay Edelberg - Officer | Grant or award | Common Stock | 47,784 | $0.00 | - | |
| Jay Edelberg - Officer | Other | Series B Preferred Stock | 61,268 | - footnote F1 | - | |
| Jay Edelberg - Officer | Other | Common Stock | 97,587 | - footnote F1 | - | |
| ||||||
Item 5.02, 7.01, 9.01
Item 2.02, 9.01
Item 5.03, 9.01
KARD insider trading FAQ
What is the latest insider trade for KARD?
Kardigan, Inc. (KARD) had 1 insider filing in the last 90 days, with the most recent on 2026-10-01. The full record for KARD runs to 17 Form 4 filings, the earliest from 2026-06-22. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying KARD stock?
No insider purchases of KARD were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling KARD stock?
No insider sales of KARD were filed in the last 90 days.
Where can I see KARD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects KARD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Kristin Marie K. Reinke view on EDGAR
- - PERCEPTIVE ADVISORS LLC view on EDGAR
- - HRTG GPE, LLC view on EDGAR
- - Paul L. Berns view on EDGAR
- - ARCH Venture Partners XIII, LLC view on EDGAR
- - HRTG GPE, LLC view on EDGAR
- - ARCH Venture Partners XIII, LLC view on EDGAR
- - Andy Pasternak view on EDGAR
- - David P. Meeker view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where KARD's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow KARD with a 7-day demo
- KARD on your watchlist
- Every KARD Form 4 filing on record
- Up to 3 months of KARD price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
